Frank T. Watkins, Director at Shockwave Medical, Inc. (SWAV), sold 2,000 shares at $253.15 ($507K) on 2024-03-06, disclosed to the SEC on 2024-03-07.
Scheduled sale ($507k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $253.15 | 1,300 | $329K | 64.9% |
| 2 | $254.57 | 700 | $178K | 35.1% |
| Total | $253.65 avg | 2,000 | $507K | 100% |
| Filing → |
| SWAV | SELL | 2023-11-21 | $926K | — | Filing → |
| SWAV | SELL | 2023-10-23 | $608K | — | Filing → |
| SWAV | SELL | 2023-09-21 | $628K | — | Filing → |